Cargando…

The World Health Organization Recommendations for Trachoma Surveillance, Experience in Nepal and Added Benefit of Testing for Antibodies to Chlamydia trachomatis pgp3 Protein: NESTS Study

BACKGROUND: The World Health Organization (WHO) now requires a second surveillance survey for trachoma after an impact assessment has found follicular trachoma (TF) <5% to determine if re-emergence has occurred. Using new WHO guidelines, we undertook surveillance surveys, and determined the preva...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zambrano, Andrea I., Sharma, Shekhar, Crowley, Kathryn, Dize, Laura, Muñoz, Beatriz E., Mishra, Sailesh K., Rotondo, Lisa A., Gaydos, Charlotte A., West, Sheila K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5031451/ https://www.ncbi.nlm.nih.gov/pubmed/27654497 http://dx.doi.org/10.1371/journal.pntd.0005003

Ejemplares similares

Longitudinal change in the serology of antibodies to Chlamydia trachomatis pgp3 in children residing in a trachoma area
por: West, Sheila K., et al.
Publicado: (2018)

The effect of Mass Drug Administration for trachoma on antibodies to Chlamydia trachomatis pgp3 in children
por: West, Sheila K., et al.
Publicado: (2020)

Risk of seroconversion and seroreversion of antibodies to Chlamydia trachomatis pgp3 in a longitudinal cohort of children in a low trachoma prevalence district in Tanzania
por: Chen, Xinyi, et al.
Publicado: (2022)

Field Evaluation of the Cepheid GeneXpert Chlamydia trachomatis Assay for Detection of Infection in a Trachoma Endemic Community in Tanzania
por: Jenson, Alexander, et al.
Publicado: (2013)

Trachoma, Anti-Pgp3 Serology, and Ocular Chlamydia trachomatis Infection in Papua New Guinea
por: Macleod, Colin K, et al.
Publicado: (2020)

Can We Use Antibodies to Chlamydia trachomatis as a Surveillance Tool for National Trachoma Control Programs? Results from a District Survey
por: West, Sheila K., et al.
Publicado: (2016)

The Performance of Immunoassays to Measure Antibodies to the Chlamydia trachomatis Antigen Pgp3 in Different Epidemiological Settings for Trachoma
por: Gwyn, Sarah, et al.
Publicado: (2021)

Measuring Trachomatous Inflammation-Intense (TI) When Prevalence Is Low Provides Data on Infection With Chlamydia trachomatis
por: Zambrano, Andrea I., et al.
Publicado: (2017)

Prevalence of signs of trachoma, ocular Chlamydia trachomatis infection and antibodies to Pgp3 in residents of Kiritimati Island, Kiribati
por: Cama, Anaseini, et al.
Publicado: (2017)

CT694 and pgp3 as Serological Tools for Monitoring Trachoma Programs
por: Goodhew, E. Brook, et al.
Publicado: (2012)

The Effect of Multiple Rounds of Mass Drug Administration on the Association between Ocular Chlamydia trachomatis Infection and Follicular Trachoma in Preschool-Aged Children
por: Lee, Jennifer S., et al.
Publicado: (2014)

Ocular Chlamydia trachomatis infection, anti-Pgp3 antibodies and conjunctival scarring in Vanuatu and Tarawa, Kiribati before antibiotic treatment for trachoma
por: Butcher, Robert, et al.
Publicado: (2020)

Pgp3 seroprevalence and associations with active trachoma and ocular Chlamydia trachomatis infection in Malawi: cross-sectional surveys in six evaluation units
por: Burr, Sarah E., et al.
Publicado: (2019)

Natural Products for the Treatment of Trachoma and Chlamydia trachomatis
por: Potroz, Michael G., et al.
Publicado: (2015)

Comparison of Platforms for Testing Antibody Responses against the Chlamydia trachomatis Antigen Pgp3
por: Gwyn, Sarah, et al.
Publicado: (2017)

Trachoma: Protective and Pathogenic Ocular Immune Responses to Chlamydia trachomatis
por: Hu, Victor H., et al.
Publicado: (2013)

Completing Baseline Mapping of Trachoma in Nepal: Results of 27 Population-Based Prevalence Surveys Conducted in 2013 and 2014
por: Sharma, Shekhar, et al.
Publicado: (2018)

Validation of immunoassays for the Chlamydia trachomatis antigen Pgp3 using a chimeric monoclonal antibody
por: Goodhew, Brook, et al.
Publicado: (2023)

The Easiest Children to Reach Are Most Likely to Be Infected with Ocular Chlamydia trachomatis in Trachoma Endemic Areas of Niger
por: Amza, Abdou, et al.
Publicado: (2013)

Evidence for contamination with C. trachomatis in the household environment of children with active Trachoma: A cross-sectional study in Kongwa, Tanzania
por: West, Sheila K., et al.
Publicado: (2019)

Control of Trachoma from Achham District, Nepal: A Cross-Sectional Study from the Nepal National Trachoma Program
por: Pant, Bidya Prasad, et al.
Publicado: (2016)

Serological Measures of Trachoma Transmission Intensity
por: Martin, Diana L., et al.
Publicado: (2015)

Treating village newcomers and travelers for trachoma: Results from ASANTE cluster randomized trial
por: West, Sheila K., et al.
Publicado: (2017)

Plasmid Negative Regulation of CPAF Expression Is Pgp4 Independent and Restricted to Invasive Chlamydia trachomatis Biovars
por: Patton, Michael John, et al.
Publicado: (2018)

Chlamydia trachomatis ompA Variants in Trachoma: What Do They Tell Us?
por: Andreasen, Aura A., et al.
Publicado: (2008)

Lack of Macrolide Resistance in Chlamydia trachomatis after Mass Azithromycin Distributions for Trachoma
por: Hong, Kevin Cyrus, et al.
Publicado: (2009)

Chlamydia trachomatis Pgp3 Antibody Population Seroprevalence before and during an Era of Widespread Opportunistic Chlamydia Screening in England (1994-2012)
por: Woodhall, Sarah C., et al.
Publicado: (2017)

Low Prevalence of Ocular Chlamydia trachomatis Infection and Active Trachoma in the Western Division of Fiji
por: Macleod, Colin K., et al.
Publicado: (2016)

Prevalence of Chlamydia trachomatis-Specific Antibodies before and after Mass Drug Administration for Trachoma in Community-Wide Surveys of Four Communities in Nepal
por: Gwyn, Sarah E., et al.
Publicado: (2018)

Latent class modeling to compare testing platforms for detection of antibodies against the Chlamydia trachomatis antigen Pgp3
por: Wiegand, Ryan E., et al.
Publicado: (2018)

Risk Factors for Ocular Infection with Chlamydia trachomatis in Children 6 Months following Mass Treatment in Tanzania
por: Cajas-Monson, Luis Carlos, et al.
Publicado: (2011)

Costs of Testing for Ocular Chlamydia trachomatis Infection Compared to Mass Drug Administration for Trachoma in The Gambia: Application of Results from the PRET Study
por: Harding-Esch, Emma, et al.
Publicado: (2015)

Conjunctival transcriptome profiling of Solomon Islanders with active trachoma in the absence of Chlamydia trachomatis infection
por: Vasileva, Hristina, et al.
Publicado: (2018)

Trachomatous Scarring and Infection With Non–Chlamydia Trachomatis Bacteria in Women in Kongwa, Tanzania
por: Cox, Jacob T., et al.
Publicado: (2017)

Active Trachoma and Ocular Chlamydia trachomatis Infection in Two Gambian Regions: On Course for Elimination by 2020?
por: Harding-Esch, Emma M., et al.
Publicado: (2009)

Chlamydia trachomatis from Australian Aboriginal people with trachoma are polyphyletic composed of multiple distinctive lineages
por: Andersson, Patiyan, et al.
Publicado: (2016)

Genomics of Ocular Chlamydia trachomatis After 5 Years of SAFE Interventions for Trachoma in Amhara, Ethiopia
por: Pickering, Harry, et al.
Publicado: (2020)

Risk Factors for Active Trachoma and Ocular Chlamydia trachomatis Infection in Treatment-Naïve Trachoma-Hyperendemic Communities of the Bijagós Archipelago, Guinea Bissau
por: Last, Anna R., et al.
Publicado: (2014)

Chlamydia trachomatis Pgp3 Antibody Persists and Correlates with Self-Reported Infection and Behavioural Risks in a Blinded Cohort Study
por: Horner, Patrick J., et al.
Publicado: (2016)

Longitudinal analysis of antibody responses to trachoma antigens before and after mass drug administration
por: Goodhew, Erica Brook, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_0l0312p5qlvmhf1r8sl9auh6pa